• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4%双氯芬酸钠喷雾凝胶对膝关节滑膜组织和滑液的渗透作用:一项随机临床试验

Penetration of topical diclofenac sodium 4 % spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial.

作者信息

Efe Turgay, Sagnak Ercan, Roessler Philip P, Getgood Alan, Patzer Thilo, Fuchs-Winkelmann Susanne, Peterlein Christian D, Schofer Markus D

机构信息

Department of Orthopaedics and Rheumatology, University Hospital Marburg, Baldingerstrasse, 35043, Marburg, Germany,

出版信息

Knee Surg Sports Traumatol Arthrosc. 2014 Feb;22(2):345-50. doi: 10.1007/s00167-013-2408-0. Epub 2013 Jan 22.

DOI:10.1007/s00167-013-2408-0
PMID:23338668
Abstract

PURPOSE

The present study was designed to evaluate the penetration of diclofenac sodium 4 % spray gel in synovial tissue, synovial fluid and blood plasma after topical application in subjects with joint effusions and planned total knee arthroplasty (TKA) due to osteoarthritis.

METHODS

A total of 39 patients were randomised to two- or three-times daily application of diclofenac sodium 4 % spray gel to knees requiring surgery over a treatment period of 3 days. Within 8 h after the last application, TKA was conducted, and the diclofenac concentrations in synovial tissue, synovial fluid and blood plasma were measured by liquid chromatography.

RESULTS

The median diclofenac concentration was approximately 10-20-fold higher in synovial tissue (36.2 and 42.8 ng/g) than in synovial fluid (2.6 and 2.8 ng/mL) or plasma (3.9 and 4.1 ng/mL) in both treatment groups. Dose proportionality for any compartment or treatment groups could not be detected. Treatment-related adverse events were noted in two cases and limited to skin reactions.

CONCLUSION

Diclofenac sodium 4 % spray gel was found to penetrate the skin locally in substantial amounts and thus reach the desired target tissue. Concentrations were not dose-dependent, and application was well tolerated by 97.4 % of patients. Topical application of diclofenac should be considered a valuable alternative to systemic NSAID therapy in the initial treatment of osteoarthritis.

摘要

目的

本研究旨在评估4%双氯芬酸钠喷雾凝胶在因骨关节炎导致关节积液并计划进行全膝关节置换术(TKA)的受试者局部应用后,在滑膜组织、滑液和血浆中的渗透情况。

方法

总共39例患者被随机分为两组,在3天的治疗期内,每天两次或三次将4%双氯芬酸钠喷雾凝胶应用于需要手术的膝盖。在最后一次应用后8小时内进行TKA手术,并通过液相色谱法测量滑膜组织、滑液和血浆中的双氯芬酸浓度。

结果

在两个治疗组中,滑膜组织中的双氯芬酸浓度中位数(36.2和42.8 ng/g)比滑液(2.6和2.8 ng/mL)或血浆(3.9和4.1 ng/mL)中大约高10至20倍。未检测到任何隔室或治疗组的剂量比例关系。有两例出现与治疗相关的不良事件,且仅限于皮肤反应。

结论

发现4%双氯芬酸钠喷雾凝胶能大量局部穿透皮肤,从而到达预期的靶组织。浓度不依赖于剂量,97.4%的患者对该应用耐受性良好。在骨关节炎的初始治疗中,双氯芬酸的局部应用应被视为全身非甾体抗炎药治疗的一种有价值替代方法。

相似文献

1
Penetration of topical diclofenac sodium 4 % spray gel into the synovial tissue and synovial fluid of the knee: a randomised clinical trial.4%双氯芬酸钠喷雾凝胶对膝关节滑膜组织和滑液的渗透作用:一项随机临床试验
Knee Surg Sports Traumatol Arthrosc. 2014 Feb;22(2):345-50. doi: 10.1007/s00167-013-2408-0. Epub 2013 Jan 22.
2
Biodistribution of diclofenac following repeated topical applications of two diclofenac sodium formulations to minipigs.两种双氯芬酸钠制剂对小型猪重复局部给药后双氯芬酸的生物分布情况。
Biopharm Drug Dispos. 2014 Mar;35(2):87-96. doi: 10.1002/bdd.1867. Epub 2013 Dec 4.
3
Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications.双氯芬酸在局部应用和口服应用后软组织及血浆中浓度的随机临床比较。
Br J Clin Pharmacol. 2009 Jan;67(1):125-9. doi: 10.1111/j.1365-2125.2008.03333.x.
4
Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease.皮肤给药后炎症性和退行性关节疾病患者滑液和血浆中的双氯芬酸浓度
Br J Clin Pharmacol. 1991 May;31(5):537-41. doi: 10.1111/j.1365-2125.1991.tb05576.x.
5
The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.非甾体抗炎药对膝骨关节炎临床结局、滑液细胞因子浓度及信号转导通路的影响:一项随机开放标签试验。
Osteoarthritis Cartilage. 2013 Sep;21(9):1400-8. doi: 10.1016/j.joca.2013.06.026.
6
The diffusion of nimesulide gel into synovial fluid: a comparison between administration routes.尼美舒利凝胶向滑液中的扩散:给药途径的比较
Int J Clin Pharmacol Ther. 2006 Jun;44(6):270-5. doi: 10.5414/cpp44270.
7
Plasma pharmacokinetics and synovial concentrations of S-flurbiprofen plaster in humans.S-氟比洛芬贴剂在人体中的血浆药代动力学及滑膜浓度
Eur J Clin Pharmacol. 2016 Jan;72(1):53-9. doi: 10.1007/s00228-015-1960-6. Epub 2015 Oct 6.
8
Disappearance kinetics of solutes from synovial fluid after intra-articular injection.关节腔内注射后溶质从滑液中的消失动力学。
Br J Clin Pharmacol. 1994 Oct;38(4):349-55. doi: 10.1111/j.1365-2125.1994.tb04365.x.
9
Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials.老年和年轻患者膝关节骨关节炎局部用双氯芬酸钠凝胶的安全性和疗效:三项随机、双盲、平行分组、安慰剂对照、多中心试验的汇总数据。
Drugs Aging. 2011 Jan 1;28(1):27-40. doi: 10.2165/11584880-000000000-00000.
10
Penetration of topical diclofenac into synovial tissue and fluid of osteoarthritic knees: a multicenter, randomized, placebo-controlled, pharmacokinetic study.双氯芬酸局部用药渗透至骨关节炎膝关节滑膜组织及滑液中的研究:一项多中心、随机、安慰剂对照的药代动力学研究
Ther Adv Musculoskelet Dis. 2020 Aug 29;12:1759720X20943088. doi: 10.1177/1759720X20943088. eCollection 2020.

引用本文的文献

1
Topical Percutaneous Drug Delivery for Allergic Diseases: A Novel Strategy for Site-Directed Pharmacologic Modulation.用于过敏性疾病的局部经皮给药:一种定向药理调节的新策略。
Pharmaceutics. 2025 Jul 2;17(7):867. doi: 10.3390/pharmaceutics17070867.
2
Relationship between Pharmacokinetic Profile and Clinical Efficacy Data of Three Different Forms of Locally Applied Flurbiprofen in the Mouth/Throat.三种不同剂型的氟比洛芬口腔/咽喉局部应用的药代动力学特征与临床疗效数据之间的关系。
Pharmaceutics. 2023 Jul 1;15(7):1863. doi: 10.3390/pharmaceutics15071863.
3
Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor.

本文引用的文献

1
Safety profile of topical diclofenac: a meta-analysis of blinded, randomized, controlled trials in musculoskeletal conditions.局部双氯芬酸的安全性概况:肌肉骨骼疾病中双盲、随机、对照试验的荟萃分析。
Curr Med Res Opin. 2011 Mar;27(3):605-22. doi: 10.1185/03007995.2010.550606. Epub 2011 Jan 13.
2
Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications.双氯芬酸在局部应用和口服应用后软组织及血浆中浓度的随机临床比较。
Br J Clin Pharmacol. 2009 Jan;67(1):125-9. doi: 10.1111/j.1365-2125.2008.03333.x.
3
Managing osteoarthritic knee pain.
双氯芬酸和其他非甾体抗炎药(NSAIDs)是人类P2X3受体的竞争性拮抗剂。
Front Pharmacol. 2023 Mar 16;14:1120360. doi: 10.3389/fphar.2023.1120360. eCollection 2023.
4
Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.非甾体抗炎药(NSAIDs)在婴儿中的疗效和安全性:对过去 20 年文献的综合回顾。
Paediatr Drugs. 2022 Nov;24(6):603-655. doi: 10.1007/s40272-022-00514-1. Epub 2022 Sep 2.
5
[Conservative treatment options for arthritis of the ankle : What is possible, what is effective?].踝关节关节炎的保守治疗选择:哪些可行,哪些有效?
Unfallchirurg. 2022 Mar;125(3):175-182. doi: 10.1007/s00113-021-01122-3. Epub 2022 Jan 18.
6
Formulation of Topical Dosage Forms Containing Synthetic and Natural Anti-Inflammatory Agents for the Treatment of Rheumatoid Arthritis.治疗类风湿关节炎的含合成和天然抗炎剂的局部剂型的制剂。
Molecules. 2020 Dec 23;26(1):24. doi: 10.3390/molecules26010024.
7
Penetration of topical diclofenac into synovial tissue and fluid of osteoarthritic knees: a multicenter, randomized, placebo-controlled, pharmacokinetic study.双氯芬酸局部用药渗透至骨关节炎膝关节滑膜组织及滑液中的研究:一项多中心、随机、安慰剂对照的药代动力学研究
Ther Adv Musculoskelet Dis. 2020 Aug 29;12:1759720X20943088. doi: 10.1177/1759720X20943088. eCollection 2020.
8
Topical Diclofenac, an Efficacious Treatment for Osteoarthritis: A Narrative Review.外用双氯芬酸:骨关节炎的有效治疗方法——一篇叙述性综述
Rheumatol Ther. 2020 Jun;7(2):217-236. doi: 10.1007/s40744-020-00196-6. Epub 2020 Feb 21.
9
Bioactive factors for cartilage repair and regeneration: Improving delivery, retention, and activity.用于软骨修复和再生的生物活性因子:提高递送、保留和活性。
Acta Biomater. 2019 Jul 15;93:222-238. doi: 10.1016/j.actbio.2019.01.061. Epub 2019 Jan 31.
10
Penetration and efficacy of transdermal NSAIDs in a model of acute joint inflammation.透皮非甾体抗炎药在急性关节炎症模型中的渗透及疗效
J Pain Res. 2018 Nov 13;11:2809-2819. doi: 10.2147/JPR.S177967. eCollection 2018.
治疗骨关节炎性膝关节疼痛。
J Am Osteopath Assoc. 2007 Nov;107(10 Suppl 6):ES21-7.
4
Persistence of NSAIDs at effect sites and rapid disappearance from side-effect compartments contributes to tolerability.非甾体抗炎药在效应部位的持续存在以及从副作用区室的快速消失有助于耐受性。
Curr Med Res Opin. 2007 Dec;23(12):2985-95. doi: 10.1185/030079907X242584.
5
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence.骨关节炎研究学会国际联盟(OARSI)关于髋和膝骨关节炎管理的建议,第一部分:对现有治疗指南的批判性评估及当前研究证据的系统评价
Osteoarthritis Cartilage. 2007 Sep;15(9):981-1000. doi: 10.1016/j.joca.2007.06.014. Epub 2007 Aug 27.
6
EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).欧洲抗风湿病联盟(EULAR)关于手部骨关节炎管理的循证推荐:EULAR国际临床研究包括治疗学常务委员会(ESCISIT)特别工作组报告
Ann Rheum Dis. 2007 Mar;66(3):377-88. doi: 10.1136/ard.2006.062091. Epub 2006 Oct 17.
7
Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation.使用新型喷雾凝胶制剂将双氯芬酸给药于皮肤后,其具有良好的皮肤渗透性。
Br J Clin Pharmacol. 2005 Nov;60(5):573-7. doi: 10.1111/j.1365-2125.2005.02484.x.
8
Topical nonsteroidal antiinflammatory drugs are effective in osteoarthritis of the knee.局部用非甾体抗炎药对膝骨关节炎有效。
J Rheumatol. 2004 Oct;31(10):1893-5.
9
Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis.用于慢性肌肉骨骼疼痛的外用非甾体抗炎药:系统评价与荟萃分析
BMC Musculoskelet Disord. 2004 Aug 19;5:28. doi: 10.1186/1471-2474-5-28.
10
Topical NSAIDs for acute pain: a meta-analysis.用于急性疼痛的外用非甾体抗炎药:一项荟萃分析。
BMC Fam Pract. 2004 May 17;5:10. doi: 10.1186/1471-2296-5-10.